Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Hepatocellular Carcinoma (HCC) is one of the most common types of primary liver cancer.
Current treatment options have limited efficacy against this malignancy, primarily owing to …
Current treatment options have limited efficacy against this malignancy, primarily owing to …
Formation of a traditional Chinese medicine self-assembly nanostrategy and its application in cancer: a promising treatment
J Huang, Y Zhu, H **ao, J Liu, S Li, Q Zheng, J Tang… - Chinese Medicine, 2023 - Springer
Traditional Chinese medicine (TCM) has been used for centuries to prevent and treat a
variety of illnesses, and its popularity is increasing worldwide. However, the clinical …
variety of illnesses, and its popularity is increasing worldwide. However, the clinical …
MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function
Z Li, H Zhou, X Zhai, L Gao, M Yang, B An, T **a… - Cell Death & …, 2023 - nature.com
Cuproptosis caused by copper overload is mediated by a novel regulatory mechanism that
differs from previously documented mechanisms regulating cell death. Cells dependent on …
differs from previously documented mechanisms regulating cell death. Cells dependent on …
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
X Zhang, T Su, Y Wu, Y Cai, L Wang, C Liang, L Zhou… - Cancer Research, 2024 - AACR
Abstract N6-methyladenosine (m6A) RNA modification is the most common and conserved
epigenetic modification in mRNA and has been shown to play important roles in cancer …
epigenetic modification in mRNA and has been shown to play important roles in cancer …
Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular …
Y Wang, K Su, C Wang, T Deng, X Liu, S Sun… - Cell Death & …, 2024 - nature.com
Chemotherapeutic efficacy is seriously impeded by chemoresistance in more than half of
hepatocellular carcinoma (HCC) patients. However, the mechanisms involved in …
hepatocellular carcinoma (HCC) patients. However, the mechanisms involved in …
POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma
H Wang, Y Liang, Z Liu, R Zhang… - Journal for …, 2024 - pmc.ncbi.nlm.nih.gov
Objective Hepatocellular carcinoma (HCC) poses a significant clinical challenge because
the long-term benefits of immune checkpoint blockade therapy are limited. A comprehensive …
the long-term benefits of immune checkpoint blockade therapy are limited. A comprehensive …
[HTML][HTML] CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent …
Aims Therapeutic outcome of sorafenib in hepatocellular carcinoma (HCC) is undermined
by the development of drug resistance. This study aimed to identify the critical microRNA …
by the development of drug resistance. This study aimed to identify the critical microRNA …
[HTML][HTML] Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the …
Q Deng, Y Huang, J Zeng, X Li, X Zheng, L Guo… - Biomedicine & …, 2024 - Elsevier
Background and aims Hepatocellular carcinoma (HCC) is one of the most common
malignancies in the world and the sixth leading cause of cancer death worldwide, and it is …
malignancies in the world and the sixth leading cause of cancer death worldwide, and it is …
Ubiquitous protein lactylation in health and diseases
J Wang, Z Wang, Q Wang, X Li, Y Guo - Cellular & Molecular Biology …, 2024 - Springer
For decades, lactate has been considered a byproduct of glycolysis. The lactate shuttle
hypothesis shifted the lactate paradigm, demonstrating that lactate not only plays important …
hypothesis shifted the lactate paradigm, demonstrating that lactate not only plays important …
[HTML][HTML] Natural Product Auraptene Targets SLC7A11 for Degradation and Induces Hepatocellular Carcinoma Ferroptosis
D Li, Y Li, L Chen, C Gao, B Dai, W Yu, H Yang, J Pi… - Antioxidants, 2024 - mdpi.com
The natural product auraptene can influence tumor cell proliferation and invasion, but its
effect on hepatocellular carcinoma (HCC) cells is unknown. Here, we report that auraptene …
effect on hepatocellular carcinoma (HCC) cells is unknown. Here, we report that auraptene …